Results 181 to 190 of about 33,507 (210)
Some of the next articles are maybe not open access.
Treatment of Neurofibromatosis Type 1
Current Treatment Options in Neurology, 2015Neurofibromatosis type 1 (NF1) is a genetic multisystemic disorder involving the skin, the central and peripheral nervous systems, bones, and the cardiovascular and endocrine systems. This condition is caused by inherited or de novo mutations of the NF1 gene at the 17q11.2 chromosomal region, a gene that codes for the protein neurofibromin ...
C. Sabatini +4 more
openaire +5 more sources
Archives of Neurology, 1999
Neurofibromatosis (NF) has perhaps been the most notorious of the neurocutaneous disorders. Both Quasimoto of Victor Hugo's The Hunchback of Notre Dame and John Merrick, known as the Elephant Man (who subsequently has been more properly classified as having Proteus syndrome, a quite different disorder), are 2 infamous examples that have shaped many ...
openaire +2 more sources
Neurofibromatosis (NF) has perhaps been the most notorious of the neurocutaneous disorders. Both Quasimoto of Victor Hugo's The Hunchback of Notre Dame and John Merrick, known as the Elephant Man (who subsequently has been more properly classified as having Proteus syndrome, a quite different disorder), are 2 infamous examples that have shaped many ...
openaire +2 more sources
Neurofibromatosis Type 1 Revisited
Pediatrics, 2009Neurofibromatosis type 1 (NF1) is an autosomal dominant condition with a worldwide incidence of ∼1 per 2500 to 3000 individuals. Caused by a germ-line–inactivating mutation in the NF1 gene on chromosome 17, the disease is associated with increased morbidity and mortality.
Virginia C, Williams +5 more
openaire +2 more sources
The Neurofibromatosis Type 1 Gene
Annual Review of Neuroscience, 1993Sometimes referred to as peripheral neurofibromatosis or von Reck linghausen disease, neurofibromatosis 1 (NFl) is one of the most common medical conditions inherited in human populations. NFl , inherited as an autosomal dominant, affects approximately 1 in 3500 individuals world wide with no apparent ethnic predilection.
D, Viskochil, R, White, R, Cawthon
openaire +2 more sources
Neurofibromatosis type 1 in children
American Journal of Ophthalmology, 1996To document ophthalmic and general characteristics of Neurofibromatosis Type 1 (NF1) in children; and to characterize the iris changes of NF1 including their variability and reliability.One hundred and ninety-six patients with NF1 were evaluated for general characteristics; 156 patients underwent prospective eye evaluations; and 151 NF1 patients and ...
openaire +2 more sources
Neurofibromatosis Types 1 and 2
The Neurologist, 2006Neurofibromatosis types 1 and 2 (NF1 and NF2) are autosomal dominant neurocutaneous disorders with some similarities and many differences. They are frequently discussed together and often confused for one another by clinicians. Both disorders have widely variable presentations and degrees of severity. A thorough understanding of these complex disorders
openaire +2 more sources
Epilepsy in neurofibromatosis type 1
Epilepsy & Behavior, 2017To describe the characteristics of epilepsy in patients with Neurofibromatosis type 1 (NF1).Analysis of a cohort of consecutive NF1 patients seen in our NF1 clinic during a three-year period.Of the 184 NF1 patients seen during that period, 26 had epilepsy and three had febrile seizures.
Anthony, Pecoraro +9 more
openaire +2 more sources
Pruritus in neurofibromatosis type 1
Italian Journal of Dermatology and Venereology, 2018Pruritus in neurofibromatosis type ...
Miraglia, Emanuele +2 more
openaire +3 more sources
Epilepsy surgery in Neurofibromatosis Type 1
Epilepsy Research, 2013Epilepsy is relatively uncommon in patients with Neurofibromatosis Type 1 (NF1) and seizures are usually well controlled with antiepileptic treatment. However, pharmacoresistance has been reported in patients with NF1 and MRI evidence of malformations of cortical development or glioneuronal tumours.
Barba C +15 more
openaire +4 more sources